{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:44:42Z","timestamp":1789742682150,"version":"4.0.1"},"reference-count":23,"publisher":"Europa Digital & Publishing","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.4244\/eijy14m07_11","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T17:02:39Z","timestamp":1428944559000},"page":"1144-1153","source":"Crossref","is-referenced-by-count":359,"title":["Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry"],"prefix":"10.4244","volume":"10","author":[{"given":"Davide","family":"Capodanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Nef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Latib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julinda","family":"Mehilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Lesiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caramanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Capranzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Araszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Pyxaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Mattesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Tamburino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-201522016821-0","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"379","author":"Palmerini T.","year":"2012","journal-title":"Lancet."},{"key":"key-201522016821-1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents.","volume":"368","author":"Stefanini GG.","year":"2013","journal-title":"N Engl J Med."},{"key":"key-201522016821-2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?","volume":"123","author":"Onuma Y.","year":"2011","journal-title":"Circulation."},{"key":"key-201522016821-3","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.","volume":"58","author":"Serruys PW.","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201522016821-4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4244\/EIJV10I2A38","article-title":"Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH).","volume":"10","author":"Simsek C.","year":"2013","journal-title":"EuroIntervention."},{"key":"key-201522016821-5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jcin.2014.01.155","article-title":"1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.","volume":"7","author":"Muramatsu T.","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201522016821-6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4244\/EIJV9I9A176","article-title":"Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes.","volume":"9","author":"Gori T.","year":"2014","journal-title":"EuroIntervention."},{"key":"key-201522016821-7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/eurheartj\/eht545","article-title":"Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study \u2018Prague 19\u2019.","volume":"35","author":"Kocka V.","year":"2014","journal-title":"Eur Heart J."},{"key":"key-201522016821-8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/eurheartj\/eht546","article-title":"Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.","volume":"35","author":"Diletti R.","year":"2014","journal-title":"Eur Heart J."},{"key":"key-201522016821-9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ahj.2012.08.010","article-title":"ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.","volume":"164","author":"Diletti R.","year":"2012","journal-title":"Am Heart J."},{"key":"key-201522016821-10","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-201522016821-11","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/eurheartj\/ehs105","article-title":"Third universal definition of myocardial infarction.","volume":"33","author":"Taylor J.","year":"2012","journal-title":"Eur Heart J."},{"key":"key-201522016821-12","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.jacc.2013.08.725","article-title":"Stent thrombosis with drug-eluting stents: is the paradigm shifting?","volume":"62","author":"Palmerini T.","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"key-201522016821-13","article-title":"Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial.","volume":"Epub AOP","author":"Nakatani S.","year":"2014 Feb 27.","journal-title":"EuroIntervention."},{"key":"key-201522016821-14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.","volume":"363","author":"Serruys PW.","year":"2010","journal-title":"N Engl J Med."},{"key":"key-201522016821-15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.","volume":"59","author":"von Birgelen C.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-201522016821-16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.111.031070","article-title":"Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.","volume":"124","author":"Stone GW.","year":"2011","journal-title":"Circulation."},{"key":"key-201522016821-17","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.jacc.2014.01.064","article-title":"Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials.","volume":"63","author":"Kedhi E.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-201522016821-18","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jacc.2010.07.016","article-title":"Stent thrombosis.","volume":"56","author":"Holmes DR Jr.","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"key-201522016821-19","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jacc.2014.01.019","article-title":"Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition.","volume":"63","author":"Attizzani GF.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-201522016821-20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jcin.2009.10.001","article-title":"Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry.","volume":"2","author":"Lotan C.","year":"2009","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201522016821-21","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jcin.2011.08.010","article-title":"A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study).","volume":"4","author":"Krucoff MW.","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201522016821-22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.","volume":"123","author":"Kolandaivelu K.","year":"2011","journal-title":"Circulation."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T10:54:17Z","timestamp":1566557657000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/81st_issue\/189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["20140707-06"],"URL":"https:\/\/doi.org\/10.4244\/eijy14m07_11","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}